Brammer Bio, LLC, a leading player in the biopharmaceutical industry, is headquartered in the United States, with significant operational regions across North America and Europe. Founded in 2018, the company has quickly established itself as a trusted partner in the development and manufacturing of advanced therapies, particularly in the field of gene and cell therapy. Brammer Bio offers a unique suite of services, including viral vector manufacturing and process development, tailored to meet the specific needs of its clients. The company’s commitment to quality and innovation has positioned it as a key contributor to the rapidly evolving landscape of biotherapeutics. With a focus on accelerating the delivery of life-changing therapies, Brammer Bio continues to achieve notable milestones, solidifying its reputation as a leader in the contract development and manufacturing organisation (CDMO) sector.
We don't have data for Brammer Bio, LLC, but we can show you information about their parent organization instead.
View parent company